PubMed

Smoking and progression of diabetic nephropathy in type 1 diabetes.

Hovind P, Rossing P, Tarnow L, Parving HH.

Diabetes Care. 2003 Mar;26(3):911-6.PMID: 12610058 [PubMed - indexed for MEDLINE]Related articlesFree article

Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.

Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH.

Kidney Int. 2001 Jul;60(1):277-83.PMID: 11422762 [PubMed - indexed for MEDLINE]Related articlesFree article

Remission of nephrotic-range albuminuria in type 1 diabetic patients.

Hovind P, Rossing P, Tarnow L, Toft H, Parving J, Parving HH.

Diabetes Care. 2001 Nov;24(11):1972-7.PMID: 11679467 [PubMed - indexed for MEDLINE]Related articlesFree article

Progression of diabetic nephropathy.

Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH.

Kidney Int. 2001 Feb;59(2):702-9.PMID: 11168952 [PubMed - indexed for MEDLINE]Related articlesFree article

Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy.

Christensen PK, Rossing P, Nielsen FS, Parving HH.

Diabet Med. 1999 May;16(5):388-94.PMID: 10342338 [PubMed - indexed for MEDLINE]Related articles

Progression of nephropathy in type 2 diabetic patients.

Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH.

Kidney Int. 2004 Oct;66(4):1596-605.PMID: 15458456 [PubMed - indexed for MEDLINE]Related articles

PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients.

Jacobsen P, Grarup N, Tarnow L, Parving HH, Pedersen O.

Nephrol Dial Transplant. 2002 Aug;17(8):1408-12.PMID: 12147787 [PubMed - indexed for MEDLINE]Related articlesFree article

Progression of diabetic nephropathy in normotensive type 1 diabetic patients.

Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, Parving HH.

Kidney Int Suppl. 1999 Jul;71:S101-5.PMID: 10412749 [PubMed - indexed for MEDLINE]Related articles

Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH.

Diabetes Care. 2003 May;26(5):1501-6.PMID: 12716812 [PubMed - indexed for MEDLINE]Related articlesFree article

Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy.

Hovind P, Tarnow L, Rossing P, Carstensen B, Parving HH.

Kidney Int. 2004 Sep;66(3):1180-6.PMID: 15327415 [PubMed - indexed for MEDLINE]Related articles

Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.

Hovind P, Tarnow L, Oestergaard PB, Parving HH.

Kidney Int Suppl. 2000 Apr;75:S56-61.PMID: 10828763 [PubMed - indexed for MEDLINE]Related articles

Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study.

Mathiesen ER, Feldt-Rasmussen B, Hommel E, Deckert T, Parving HH.

Diabetes Care. 1997 Mar;20(3):286-9.PMID: 9051373 [PubMed - indexed for MEDLINE]Related articles

The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.

Gall MA, Nielsen FS, Smidt UM, Parving HH.

Diabetologia. 1993 Oct;36(10):1071-8.PMID: 8243857 [PubMed - indexed for MEDLINE]Related articles

Aldosterone synthase (CYP11B2) -344T/C polymorphism is not associated with the initiation and progression of diabetic nephropathy in Caucasian Type 1 diabetic patients.

Lajer M, Schjoedt KJ, Jacobsen P, Tarnow L, Parving HH.

Diabet Med. 2006 Jun;23(6):675-80.PMID: 16759311 [PubMed - indexed for MEDLINE]Related articles

Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.

Parving HH, Hommel E, Jensen BR, Hansen HP.

Kidney Int. 2001 Jul;60(1):228-34.PMID: 11422755 [PubMed - indexed for MEDLINE]Related articlesFree article

Rate of decline of GFR and progression of vascular disease in type 2 diabetic patients with diabetic or vascular nephropathy during the last three years before starting dialysis therapy.

Biesenbach G, Schmekal B, Pieringer H, Janko O.

Kidney Blood Press Res. 2006;29(5):267-72. Epub 2006 Oct 11.PMID: 17035711 [PubMed - indexed for MEDLINE]Related articles

Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.

Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G.

Am J Kidney Dis. 2000 Jun;35(6):1155-65.PMID: 10845831 [PubMed - indexed for MEDLINE]Related articles

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P.

Diabetes Care. 2008 Apr;31(4):747-52. Epub 2007 Dec 27.PMID: 18162497 [PubMed - indexed for MEDLINE]Related articlesFree article

Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).

Svensson M, Sundkvist G, Arnqvist HJ, Björk E, Blohmé G, Bolinder J, Henricsson M, Nyström L, Torffvit O, Waernbaum I, Ostman J, Eriksson JW; Diabetes Incidence Study in Sweden (DISS).

Diabetes Care. 2003 Oct;26(10):2903-9.PMID: 14514599 [PubMed - indexed for MEDLINE]Related articlesFree article

Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.

Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo Perin P; Casale Monferrato Study.

Diabetes Care. 2003 Jul;26(7):2150-5.PMID: 12832328 [PubMed - indexed for MEDLINE]Related articlesFree article